Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Other financing activities (2016 - 2025)

Historic Other financing activities for Merit Medical Systems (MMSI) over the last 13 years, with Q3 2025 value amounting to $12.5 million.

  • Merit Medical Systems' Other financing activities rose 10949.92% to $12.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.8 million, marking a year-over-year increase of 2514.5%. This contributed to the annual value of $25.8 million for FY2024, which is 3523.6% up from last year.
  • According to the latest figures from Q3 2025, Merit Medical Systems' Other financing activities is $12.5 million, which was up 10949.92% from $9.9 million recorded in Q2 2025.
  • Merit Medical Systems' Other financing activities' 5-year high stood at $13.8 million during Q4 2023, with a 5-year trough of $4.9 million in Q1 2024.
  • Over the past 3 years, Merit Medical Systems' median Other financing activities value was $8.2 million (recorded in 2024), while the average stood at $8.7 million.
  • In the last 5 years, Merit Medical Systems' Other financing activities crashed by 3821.63% in 2024 and then surged by 10949.92% in 2025.
  • Over the past 3 years, Merit Medical Systems' Other financing activities (Quarter) stood at $13.8 million in 2023, then tumbled by 38.22% to $8.5 million in 2024, then soared by 47.15% to $12.5 million in 2025.
  • Its last three reported values are $12.5 million in Q3 2025, $9.9 million for Q2 2025, and $7.9 million during Q1 2025.